What is Tango Therapeutics Inc (TNGX)?
Tango Therapeutics Inc is a biotechnology company focused on developing targeted cancer therapies. The company leverages synthetic lethality and precision medicine approaches to identify and develop novel therapeutics aimed at exploiting specific genetic vulnerabilities in cancer cells. Tango Therapeutics employs advanced genomic and computational technologies to discover drug candidates that selectively kill tumor cells while sparing normal tissues. Its research pipeline includes small molecules and other modalities designed to address unmet medical needs in oncology. The company collaborates with academic institutions and industry partners to advance its drug development programs. Tango Therapeutics operates within the broader biopharmaceutical sector, contributing to the innovation of cancer treatment options through its scientific expertise and technology platforms.
Tango Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by intraday market trends, with Tango Therapeutics Inc currently at $19.91. The trading price ranged between $19.63 and $20.91, reflecting a change of -4.6747% for the day.
FAQ: Tango Therapeutics Inc (TNGX)
What is the current price of TNGX stock?
The current trading price is $19.91.
Does TNGX pay dividends?
The company pays dividends via cash distributions (if applicable).
Does TNGX have a formal corporate presence or regional headquarters in the UAE?
Tango Therapeutics Inc does not have an official regional office, subsidiary, or registered presence in the UAE and operates via partners or distributors.
What is TNGX best known for?
Tango Therapeutics Inc is most famous for its development of targeted cancer therapies.
What assets are typically shown together with TNGX?
Commonly shown alongside TNGX: BLACKROCK THROGMORTON TRUST PLC, Chemed Corp, State Street SPDR S&P Biotech ETF
Latest shares articles



